Clinical Trials
23 trialsProton Radiation for Chordomas and Chondrosarcomas
Abramson Cancer Center at Penn Medicine
PRIMHADRON
Hospices Civils de Lyon
Grade 2 Chondrosarcoma Treated by Intralesional Curettage: Follow-up vs Resection
IRCCS Azienda Ospedaliero-Universitaria di Bologna
ImmunoSarc
Grupo Espanol de Investigacion en Sarcomas
Iodine I 131 Monoclonal Antibody 3F8 in Treating Patients With Central Nervous System Cancer or Leptomeningeal Cancer
Memorial Sloan Kettering Cancer Center
Osteosarcoma
Stanford University
AIAC
Peking University People's Hospital
MACIST
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Safety and Efficacy Study of Torisel and Liposomal Doxorubicin for Patients With Recurrent Sarcoma
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Trial of Dasatinib in Advanced Sarcomas
Sarcoma Alliance for Research through Collaboration
Therapeutic Angiotensin-(1-7) in Treating Patients With Metastatic Sarcoma That Cannot Be Removed By Surgery
Wake Forest University Health Sciences
Apatinib for Advanced Sarcoma: Results From Multiple Institutions' Off-label Use
Peking University People's Hospital
CH01
University of Florida
Charged Particle RT for Chordomas and Chondrosarcomas of the Base of Skull or Cervical Spine
Massachusetts General Hospital
High-dose ICE With Amifostine
Dana-Farber Cancer Institute
CONDRO1
Istituto Ortopedico Rizzoli
Celecoxib and Radiation Therapy in Treating Patients With Stage II or Stage III Soft Tissue Sarcoma of the Arm, Hand, Leg, or Foot That Has Been Removed by Surgery
University of Miami
Sunitinib in Treating Patients With Metastatic, Locally Advanced, or Locally Recurrent Sarcomas
Memorial Sloan Kettering Cancer Center
Irradiated Donor Lymphocyte Infusion in Treating Patients With Relapsed or Refractory Hematologic Cancer or Solid Tumor
Rutgers, The State University of New Jersey
Combination Chemotherapy Plus Filgrastim in Treating Patients With Advanced Solid Tumors
Dartmouth-Hitchcock Medical Center
Combination Chemotherapy Followed by Bone Marrow Transplantation in Treating Patients With Rare Cancer
Memorial Sloan Kettering Cancer Center
Gemcitabine and Docetaxel in Treating Patients With Recurrent Osteosarcoma (Closed to Accrual as of 12/21/06) or Ewing's Sarcoma or Unresectable or Locally Recurrent Chondrosarcoma
Sarcoma Alliance for Research through Collaboration
Thalidomide and Docetaxel in Treating Patients With Advanced Cancer
Case Comprehensive Cancer Center